Diversity & Inclusion Initiatives
The Company believes that it is important to respect diverse values in order to achieve sustainable growth and enhance corporate value, and by building a diverse organization that is not limited by gender, age, nationality, race, or other attributes, and by fostering a corporate culture in which all employees can play an active role, the Company will create new innovations and continue to enhance its own value as a growing company.
- For more details, please see the other page "Diversity & Inclusion"
Gender Diversity Initiatives
The Company is committed to gender diversity (women's advancement) as a step toward strongly promoting diversity that respects diverse values.
The ESG Committee has identified 11 material issues (the most important issues) and has established and disclosed a company-wide action plan with indicators and targets. Among these, under the material issue "Employee Engagement," we aim to create value through "p romotion of active roles for diverse human resources " as one of our KPIs, and as a central measure, we are strongly promoting women's activities. Furthermore, one of the strategies in the Medium-Term Management Plan is "Development of human resources to realize growth strategies," and one of our targets is "Creating an environment in which a diverse range of human resources, including women, professionals, and seniors, can play an active role."
In order to further increase our recognition as a company that stands by women, we are strongly promoting women's advancement in key positions in our organization and will focus on developing female managers by providing a comfortable work environment, fostering career orientation, and enhancing our education and training system to expand their capabilities.
Atsushi Maruo
Senior Managing Member of the Board of Directors, Representative Director
Gender Diversity Promotion Structure
The Company is committed to implementing measures throughout the Group to encourage the growth of highly motivated women. This system is headed by the Representative Director and Senior Managing Director, with the Group Business Management Division playing a central role, in cooperation with the entire Group and its various divisions, and promotes the creation of an organization that enables women to play an active role without being restricted by gender differences.
As a company that supports women's health at every stage of their lives, we consider the promotion of women's advancement in our company to be an urgent issue, and we consider it an important social mission of our company to drive the advancement of women in society as a whole by promoting this issue, as well as an important indicator that leads to the enhancement of corporate value.
Voluntary Action Plan for Female Officers
Based on the judgment that the presence of multiple female officers is essential to reflect diverse
perspectives and values among the officers responsible for making important corporate policy
decisions, we have also set an indicator for the percentage of female officers and have aimed to
nurture female officers within the Company.
As a result of our efforts, we had our first female
Board member in June 2022.
Maiko Mori
Member of the Board of Directors, Executive Corporate Officer -
ASKA Pharmaceutical Holdings Co., Ltd.
Member of the board of Directors, Executive Corporate
Officer
Division Director, Quality & Safety Assurance Division - ASKA Pharmaceutical Co.,
Ltd.
As a leading company protecting women’s health in all
fields,
we promote an organization where women can play an active and vibrant role
Against the backdrop of increasingly fierce global competition, accelerating changes in the industrial structure, and an aging society with a declining birthrate, businesses, including our own, are now required to address human capital issues such as realizing work-style reforms and addressing labor shortages in the market. Among these, the reform of human resource strategies is essential, and diversity management, including women’s advancement, is required as one of the pillars of such reforms.
Among the many pharmaceutical companies, we specialize in the field of obstetrics and gynecology, and we are aiming to raise our awareness as a company that is close to women. Moreover, I expect that in the future there will be a growing demand from women in general toward companies that are close to women, from the viewpoint of customers. In light of this, we have decided to specifically address gender diversity (women’s advancement) as a step toward strongly promoting diversity in our company.
What are the needs and challenges in further promoting gender diversity in our group?
Mori
The challenge is to what extent the company can support the individual values that each employee
believes in. Life events such as childcare and nursing care are directly related to each
individual’s work style, and all are critical issues when promoting the success of women.
Even if
a system is in place, I would like to see an environment where people can build personal
relationships,
discuss minor problems in the workplace, and help each other out. Creating an even more open
workplace
than now may be the driver to accelerate the promotion of women’s activities.
In the
future, we
will enhance support for women’s life events and for balancing work and childcare by making
comparisons with other companies’ precedents, and we will also communicate through training
programs how the management level should be, for example, correcting stereotypes about working
styles.
Ms. Mori, please give us a message, as our first female Board member, to female employees who wish to advance their careers.
Mori
I do not believe by any means that I have walked alone to my current position as a Board member. I
have
received support from many colleagues, supervisors, subordinates, family members, and
friends.
If you
are ever approached by a company for a management position, I would like you to try first. I feel
that
it would be a shame to underestimate yourself and put the brakes on an excellent person saying,
“I
can’t do it,” even if the opportunity comes your way. The Company does not expect
female
managers to have the same work style as before.
The Company aims to create an organization in
which
women can thrive in all fields through innovation and by bringing together your various values,
personalities, and strengths to express your own identity. Let’s move forward together.
Promoting Advancement of Women - General Employer Action Plan
ASKA Pharmaceutical regards “Contributing to Women’s Health” as one of its key missions and strives to provide healthcare that supports women throughout the various stages of their lives. To fulfill this mission, we believe it is essential to create an environment in which diverse talent can fully demonstrate their capabilities and diverse perspectives can be reflected in our business activities.
In particular, we consider the advancement of women within the Company to be an important management priority, as we believe that promoting women’s advancement within our own organization will also contribute to the advancement of women in society as a whole.
In accordance with the Act on the Promotion of Women’s Active Engagement in Professional Life, ASKA Pharmaceutical has formulated and implemented General Employer Action Plans since 2016 and has continuously worked to promote women’s advancement. Through initiatives such as supporting employees in balancing work with childcare and nursing care, promoting flexible work arrangements, supporting career development, and enhancing education and training programs, we are working to create a workplace environment in which everyone can fully demonstrate their capabilities. Building on these initiatives, we are implementing our Fourth General Employer Action Plan, which focuses on three key areas: systematic development of female talent with a view to appointment to management positions, further promotion of flexible work arrangements, and enhanced support for maintaining and improving employees’ physical and mental health.
Under the Fourth General Employer Action Plan, launched in FY2025, we have identified the following priority initiatives: systematic development of female talent with a view to appointment to management positions, further promotion of flexible work arrangements, and enhanced support for maintaining and improving physical and mental health.
By taking an integrated approach to recruitment, development, assignment, and promotion, and by expanding both the number of women in management positions and the pipeline of female candidates for such positions, we will continue to build an organization in which diverse talent can thrive. Through these efforts, we aim to strengthen the competitiveness of our business, particularly in the field of women’s healthcare, and achieve sustainable enhancement of corporate value.
| Plan Period: April 1, 2025 to March 31, 2030 | |
|---|---|
| Target 1 |
Target percentage of women in management positions: 20% or more
|
| Target 2 |
Percentage of eligible male employees taking childcare leave: 100%
|
| Target 3 |
Enhance employees’ physical and mental well-being through health and productivity management
|
Examples of Initiatives
Systems and Evaluation
- Introduction of Role Grading and Single Rate Compensation System
- 360-degree evaluation
- Internal job posting career challenge system
- Career self-reporting system
Education and Training
- Opinion exchange meeting for women’s advancement by management
- Selective training for female manager candidates
- Level-specific for managers at all levels
- Elective training programs for the development of next-generation management leaders
- Introduction of a self-learning system for building career ownership
- Workshops on women’s health
Support for balancing both work and private life to enhance work-life balance
- Full-flexible work system with no minimum working hours: three or more days off per week possible
- Annual paid leave in increments of one hour
- Telecommuting
- Remote work and work location limited system
- Shorter working hours and staggered working hours
- Infertility Treatment Support Program
- Paid childcare leave: five consecutive days after taking leave
- Male employees taking childcare leave Target: 100% or more
- Extended Caregiver Leave (up to One Year from the Start of Leave)
- Annual paid leave utilization rate Target: 75% or more
- Refreshment leave, leave for morning sickness and for menstrual periods, bone marrow donor leave, volunteer leave
- Consultation services by occupational health staff and introduction of external EAP (Employee Assistance Program) services
- Cancer Insurance Coverage for Regular Employees
- GLTD (Group Long-Term Disability) Insurance Coverage for Regular Employees
- Health and Productivity Management Initiatives (including Thyroid Function Testing, Ferritin Level Testing, Prostate Cancer Screening, Uterine and Ovarian Cancer Tumor Marker Testing, Gastric Cancer ABC Screening, and Breast and Cervical Cancer Screening)
- Work Support Grant Program
In-house Workshops by Health Lab Mint+ for Women’s health
We held a workshop on women's health for all employees, both male and female, with the aim of creating
a more comfortable work environment where all employees have proper knowledge about women's health and
understand each other's problems that are specific to women. The attendance rate for this workshop was
approximately 96%, and the results of a post-workshop questionnaire showed that both the level of
understanding and satisfaction exceeded 90%, indicating a high level of interest in the subject.
We will continue to hold such workshops.
Collection of Related Data on Women's Advancement
Please refer to the ESG Chart and ESG Data Book for the latest information.
External Evaluation
Next Nadeshiko: Companies Supporting Dual-career and Co-parenting
As a new effort starting in FY2023, “Next Nadeshiko: Companies Supporting Dual-career and Coparenting” started as an initiative that selects outstanding companies for their efforts related to the “support for dual-career and co-parenting” regardless of gender from listed companies that have applied for “Nadeshiko Brands.” Since its first selection in March 2025, the Company has been selected for two consecutive years.
Platinum Kurumin Plus Certification
In March 2026, ASKA Pharmaceutical Co., Ltd., a core operating company of the ASKA Pharmaceutical Holdings Group, obtained the “Platinum Kurumin Plus” certification for the first time from the Tokyo Labour Bureau of the Ministry of Health, Labour and Welfare. This certification is awarded to companies that meet certain criteria by actively promoting a high standard of childcare support, as well as support for balancing infertility treatment and work. The ASKA Pharmaceutical Holdings Group is committed to creating a workplace environment in which all employees can fully demonstrate their abilities while balancing diverse life events, and these initiatives have been highly evaluated.
Eruboshi (Receives Highest-Level Three-Star) certification
In July 2026, ASKA Pharmaceutical Co., Ltd., a core operating company of the ASKA Pharmaceutical Holdings Group, obtained the “Eruboshi (Level 3)” certification for the first time from the Tokyo Labour Bureau of the Ministry of Health, Labour and Welfare. This certification is awarded to companies that meet all five criteria under the Act on Promotion of Women’s Participation and Advancement in the Workplace: recruitment, continued employment, working hours and work styles, the ratio of women in management positions, and diverse career paths. The ASKA Pharmaceutical Holdings Group is committed to creating a workplace environment in which all employees, regardless of gender, can fully demonstrate their abilities and build long-term careers, and these initiatives have been highly evaluated.
Tokyo Women's Empowerment Awards
Since 2014, the Tokyo Metropolitan Government has been presenting awards to companies, groups, and individuals that are working to promote the active participation of women in the workplace, with the aim of creating a society in which all women can make a diverse range of choices in accordance with their ambitions and abilities. In 2024, ASKA Pharmaceutical Co., Ltd. received an award of excellence in the business category of the Tokyo Women's Empowerment Awards.